Boosting Pharmaceutical Innovation in the Post-TRIPS Era

Boosting Pharmaceutical Innovation in the Post-TRIPS Era

Real-Life Lessons for the Developing World

Burcu Kilic

This timely book investigates the concept of innovation and illustrates the crucial role that patent strategies play within processes of pharmaceutical innovation. Drawing on extensive country and company case studies, it identifies the key issues relevant to the revival of local pharmaceutical industries. Based on an understanding of the post-TRIPS environment and case studies of national innovation strategies, it specifically addresses an important question – to what extent can lessons from national experiences be transferred to current policy developments for innovation in the pharmaceutical industry in a developing country context?

Chapter 4: Looking at the big picture: national innovation system

Burcu Kilic

Subjects: law - academic, biotechnology and pharmaceutical law, intellectual property law


Since the introduction of the Agreement on the Trade Related Aspects of Intellectual property Rights (TRIPS), the intellectual property (IP) landscape has changed dramatically. Eventually, intellectual property rights (IPRs) came to be linked with innovation. It is widely accepted that IPRs are economic assets that are necessary to develop world-class standards of innovation and creativity. Thus, they should be considered as forming part of a broader set of measures that are designed to optimise the development and utilisation of knowledge. While many scholars and international organisations approach IPRs simply from a legal angle, it is important to open up debate about IPRs as an essential component of innovation by integrating legal, political, technological and socio-economic considerations. The debates are still ongoing between countries, politicians, non-governmental organisations (NGOs) and academics on TRIPS and innovation. Nevertheless, one thing is clear – TRIPS still remains in place. Given the recent trend of free trade agreements (FTAs), we would be lucky if TRIPS continues to remain in place. A better understanding of the nature of TRIPS, and its components, can help to raise awareness of the need for a comprehensive innovation policy. Hence, it is important to outline the issues surrounding the concept of IPRs and innovation. The systematic promotion of innovation has arguably resulted in innovation becoming a part of the development agenda. Innovation, particularly in developing countries, increasingly takes both legal and economic scholars into account.

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information